Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson’s disease
暂无分享,去创建一个
Viviana Versace | Giacomo Koch | D. Centonze | G. Bernardi | P. Stanzione | G. Koch | V. Versace | L. Brusa | Giorgio Bernardi | Diego Centonze | Livia Brusa | Paolo Stanzione | Cesare Iani | C. Iani
[1] J A Obeso,et al. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. , 2000, Annals of neurology.
[2] S. Tsuji,et al. Does transcranial magnetic stimulation improve the motor symptoms of Parkinson disease? , 2003, Journal of Neurology.
[3] Erwan Bezard,et al. Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies , 2001, Nature Reviews Neuroscience.
[4] M. Gentilucci,et al. Planning and executing an action in Parkinson's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.
[5] Alexander Münchau,et al. Repeated premotor rTMS leads to cumulative plastic changes of motor cortex excitability in humans , 2003, NeuroImage.
[6] T. Paus,et al. Repetitive Transcranial Magnetic Stimulation of the Human Prefrontal Cortex Induces Dopamine Release in the Caudate Nucleus , 2001, The Journal of Neuroscience.
[7] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[8] G. Di Chiara,et al. Cocaine and Amphetamine Increase Extracellular Dopamine in the Nucleus Accumbens of Mice Lacking the Dopamine Transporter Gene , 2001, The Journal of Neuroscience.
[9] Sarah H Lisanby,et al. Therapeutic application of repetitive transcranial magnetic stimulation: a review , 2001, Clinical Neurophysiology.
[10] C. Civardi,et al. Transcranial magnetic stimulation and Parkinson’s disease , 2002, Brain Research Reviews.
[11] C. Weiller,et al. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease. , 2004, Brain : a journal of neurology.
[12] J. Rothwell,et al. Functional Connectivity of Human Premotor and Motor Cortex Explored with Repetitive Transcranial Magnetic Stimulation , 2002, The Journal of Neuroscience.
[13] Idil Cavus,et al. Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders. , 2002, The American journal of psychiatry.
[14] D J Brooks,et al. Neuroimaging of dyskinesia. , 2000, Annals of neurology.
[15] J. Dostrovsky,et al. Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine. , 2000, Annals of neurology.
[16] D. Brooks,et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. , 2000, The New England journal of medicine.
[17] C Caltagirone,et al. High-frequency rTMS improves time perception in Parkinson disease , 2004, Neurology.
[18] Paul Greengard,et al. Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia , 2003, Nature Neuroscience.
[19] U Sabatini,et al. Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia. , 1998, Brain : a journal of neurology.
[20] S. Fahn. Unified Parkinson's Disease Rating Scale , 1987 .
[21] M. Hallett,et al. Depression of motor cortex excitability by low‐frequency transcranial magnetic stimulation , 1997, Neurology.
[22] S Fahn,et al. The spectrum of levodopa-induced dyskinesias. , 2000, Annals of neurology.
[23] O Rascol. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group , 2000 .
[24] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[25] P. May,et al. Quantitative Assessment of Neuroleptic‐Induced Extrapyramidal Symptoms: Clinical and Nonclinical Approaches , 1983, Clinical neuropharmacology.
[26] D. Brooks,et al. Core assessment program for intracerebral transplantations (CAPIT) , 1992, Movement disorders : official journal of the Movement Disorder Society.
[27] L. Grégoire,et al. Risk Factors for Peak Dose Dyskinesia in 100 Levodopa-treated Parkinsonian Patients , 1996, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[28] C Caltagirone,et al. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease , 2005, Neurology.
[29] J. Málly,et al. Improvement in Parkinsonian symptoms after repetitive transcranial magnetic stimulation , 1999, Journal of the Neurological Sciences.
[30] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .
[31] L. Tremblay,et al. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism , 1991, Brain Research.